A newly published study suggests that high blood pressure may be driven by a previously overlooked brain mechanism, offering hope for more targeted treatments for millions of people living with hypertension.
Researchers have identified a specific brain region, known as the lateral parafacial (pFL) area, that appears to play a critical role in raising blood pressure by linking breathing patterns with blood vessel constriction.
The research, conducted by scientists in Brazil and New Zealand, found that the pFL region, already known for controlling forceful exhalations during activities like exercise, coughing, or laughing, may also activate the sympathetic nervous system.
This βfight-or-flightβ response increases heart rate and tightens blood vessels, ultimately elevating blood pressure.
Hypertension affects roughly one-third of the global population, and in many cases it remains uncontrolled even with medication.
The findings could explain why as many as 40% of patients continue to experience high blood pressure despite treatment.
According to the researchers, subtle changes in breathing rhythms, often unnoticed, may trigger pFL neurons, which in turn stimulate sympathetic nerve activity and raise blood pressure.
To investigate this connection, scientists conducted experiments on rats using genetic engineering techniques to selectively activate or deactivate pFL neurons.
They monitored breathing-related nerve activity, sympathetic nervous system responses, and blood pressure levels.
When pFL neurons were activated, the animalsβ blood pressure increased significantly.
Conversely, when the same neurons were switched off, blood pressure returned to normal levels.
The study also mapped the neural circuits involved, revealing that in hypertensive rats, pFL neurons not only influenced breathing but also actively constricted blood vessels.
This dual function suggests the brainstem region may act as a key driver of neurogenic hypertension, high blood pressure caused by nervous system activity rather than purely cardiovascular factors.
Researchers believe this discovery could also help explain the long-observed link between sleep apnea and high blood pressure.
During sleep apnea episodes, oxygen levels drop and carbon dioxide levels rise, conditions known to activate pFL neurons.
This activation may trigger blood vessel tightening and sustained increases in blood pressure, raising cardiovascular risk over time.
Although the research was conducted in animal models, scientists say the mechanisms are likely similar in humans.
The findings provide a potential pathway for developing new treatments aimed at reducing overactivity in the pFL region.
However, directly targeting the brain can be difficult and risky, prompting researchers to explore alternative approaches.
One promising strategy involves the carotid bodies, small clusters of sensory cells located in the neck that detect oxygen and carbon dioxide levels in the blood.
These sensors communicate with the pFL region.
By targeting the carotid bodies with medication, scientists believe they may be able to indirectly calm pFL activity and lower blood pressure without needing drugs that penetrate the brain.
Researchers are currently testing a repurposed drug designed to suppress carotid body activity.
If successful, this approach could provide a safer and more accessible treatment for patients whose hypertension is driven by nervous system overactivity.
Despite the encouraging findings, extensive clinical testing will be required before any new therapy becomes available.
Still, experts say the discovery marks an important step forward in understanding hypertension, a condition that significantly increases the risk of heart disease, stroke, kidney problems, and even dementia.
The study was published in the journal Circulation Research and highlights the growing recognition that high blood pressure is not only a cardiovascular issue but also a neurological one.
By targeting the brain-breathing-blood vessel connection, scientists may have uncovered a new path toward controlling one of the worldβs most common and dangerous health conditions.
